00:10:27 Vickie Danaher But studies suggest that there may be a somewhat higher discontinuation rate with orforglipron compared with oral semaglutide, potentially due to these GI side effects
TRIPLE-POWER FORMULA: Experience peak performance with our nitric oxide supplement, blending L-Arginine, L-Citrulline, and L-Carnitine Tartrate
They write: The current literature supports modifying fasting recommendations for patients taking GLP-1 RAs as the most important mitigating factor
households include a GLP-1 user, implying these emerging food preferences are impacting about one out of every four consumers
Stougaard EB, Rossing P, Vistisen D et al (2023) Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, reduces the risk of cardiovascular and kidney disease as assessed by Steno T1 Risk Engine in adults with type 1 diabetes
This delivery chemistry, rather than any change to the peptide sequence, is what made an orally administered GLP-1 receptor agonist feasible